Business
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
OSR Holdings (Nasdaq: OSRH) today announced that on September 5, 2025, it received a written notification from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
About this update from Osr Holdings, Inc.
[{"type":"text","content":"BELLEVUE, Wash., Sept. 9, 2025 /PRNewswire/ -- OSR Holdings (Nasdaq: OSRH) today announced that on September 5, 2025, it received a written notification from The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.","length":379,"tagName":"p"},{"type":"image","alt":"OSR Holdings logo (PRNewsfoto/OSR Holdings)","displaySize":"","headline":null,"caption":"OSR Holdings logo (PRNewsfoto/OSR Holdings)","className":"","disableSlideshowImg":false,"size":{"original":{"width":334,"height":277,"url":"https://media.zenfs.com/en/prnewswire.com/d1cf26310f8a0d3a1f4f003318d5e702"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cTh6l6BCVhUkYFTe3KonaA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTUzMTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/d1cf26310f8a0d3a1f4f003318d5e702","width":334,"height":277}},"href":"https://mma.prnewswire.com/media/2393302/OSR_Holdings_logo_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The notice does not affect the listing of OSR Holdings' common stock, which will continue to trade on the Nasdaq Capital Market under the ticker symbol "OSRH." In accordance with Nasdaq rules, the Company has until March 4, 2026 to regain compliance.","length":264,"tagName":"p"},{"type":"text","content":"Despite recent share price volatility, OSR Holdings continues to believe that its market value does not reflect the strength of its business fundamentals or the momentum across its programs. The Company continues to:","length":216,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Advance its portfolio of transformative programs in key therapeutic areas including oral immunotherapies and regenerative medicine.","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"Build its Digital Asset Treasury (DAT) strategy to reinforce financial flexibility and resilience.","length":98,"tagName":"p"}]},{"val":[{"type":"text","content":"Conduct due diligence on Woori IO, a developer of non-invasive glucose monitoring technology, underscoring a commitment to advancing high-impact, complementary innovations.","length":172,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":401,"olType":false},{"type":...